Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that Alastair Smith, Chief Executive Officer, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.
The event will be held on Thursday, 11 June 2020 at 2pm. Please register your interest at https://voxmarkets.brand.live/c/avacta-Investor-presentation.